Researchers say: Fibromyalgia Pain May Be Linked To Spinal Cord Dysfunction


Researchers increasingly view fibromyalgia not as mere soft tissue discomfort, but as a neurological disorder rooted in spinal cord dysfunction. This emerging understanding is transforming how researchers conceptualize its cause and paving the way for new diagnostic and therapeutic strategies.


Spinal Cord Hyperexcitability Underlies Pain Amplification

In a landmark study assessing the nociceptive withdrawal reflex—an electrical test of spinal cord responsiveness—patients with fibromyalgia exhibited significantly lower reflex thresholds compared to healthy controls. This finding indicates that spinal cord neurons fire more easily in response to even mild stimulation, significantly amplifying pain signals before they reach the brain. Such "spinal cord hypersensitivity" helps explain the extreme sensitivity to gentle touches or light pressure frequently reported by fibromyalgia patients. 


Dysfunctional Pain Modulation Pathways

The spinal cord relies on descending neural pathways to regulate pain, inhibiting or facilitating sensations in downstream neurons. In fibromyalgia, these pathways appear imbalanced: inhibitory circuits are weakened while facilitatory signals are abnormally strong. Animal studies show that disruption of these descending systems increases spontaneous spinal neuron activity and heightens sensitivity to stimuli—mirroring human experiences of widespread deep-tissue pain and sensitization seen in fibromyalgia.


Evidence from Spinal Cord Imaging

Recent spinal fMRI studies provide compelling evidence of structural and functional changes in fibromyalgia. When exposed to repetitive heat stimuli designed to elicit temporal summation of pain—a hallmark of central sensitization—fibromyalgia patients showed abnormal activation of spinal cord regions and their brainstem connections compared to healthy subjects. This suggests both spinal and supraspinal circuits fail to regulate escalating pain signals, reinforcing the idea of spinal-level dysfunction. 


Biochemical Drivers: Substance P, Glutamate, Neuroinflammation

Neurochemical changes in spinal tissues are equally significant. Elevated levels of substance P and glutamate—key neurotransmitters in pain pathways—have been measured in spinal fluid of fibromyalgia patients. These molecules lower the activation threshold for spinal neurons and foster synaptic changes that prolong pain signaling, a process termed "wind-up." Ongoing neuroinflammation, including activation of glial cells, further fuels this sensitization. 


Structural Atrophy in Spinal Gray Matter

MRI studies correlating opioid use and fibromyalgia severity reveal a loss of gray matter volume in both dorsal and ventral horns of the cervical spinal cord. These horns are integral to sensory perception and motor control. While the direct cause of this atrophy remains uncertain, its correlation with heightened pain and reduced thermal tolerance hints at spinal degeneration's contribution to symptom severity.


Small-Fiber Neuropathy and Spinal Root Cyst Involvement

Emerging evidence points to a link between fibromyalgia, small-fiber neuropathy, and spinal root cysts such as Tarlov cysts. Paresthesia—tingling, burning, and numbness—is frequently reported and may stem from peripheral nerve fiber damage and cyst-induced pressure at the roots. This structural involvement reinforces spinal dysfunction as a significant factor. 


Reframing Fibromyalgia as Nociplastic and Neuropathic Pain

These spinal mechanisms align with the International Association for the Study of Pain’s definition of nociplastic pain: altered pain signaling without tissue damage. Fibromyalgia shares characteristics with neuropathic disorders—specifically, dysfunctional inhibitory processes and abnormal neuronal firing at the spinal level—blurring the lines between these classifications. 


Implications for Future Treatment

This evolving model suggests that treatments targeting spinal cord dysfunction—such as NMDA-receptor modulators, sodium channel blockers, or glial cell inhibitors—may offer new therapeutic avenues. Biofeedback and neuromodulation techniques like spinal TMS or transcutaneous spinal stimulation may help rebalance spinal circuits. The identification of spinal cysts also raises the possibility of interventional approaches, such as cerebrospinal fluid drainage.


Summary

Current research highlights a compelling connection: fibromyalgia appears to involve significant spinal cord dysfunction. Hyperreactive spinal neurons, compromised pain inhibition pathways, gray matter atrophy, biochemical sensitization, and neuroinflammation collectively contribute to the illness. This paradigm shift moves fibromyalgia beyond generalized chronic pain toward a targeted understanding rooted in spinal cord neurobiology—offering fresh hope for more effective diagnostics and treatments.

https://fibromyalgia.dashery.com/
Click here to buy this or visit fibromyalgia store

For More Information Related to Fibromyalgia Visit below sites:

References:

Fibromyalgia Contact Us Directly

Click here to Contact us Directly on Inbox

Official Fibromyalgia Blogs

Click here to Get the latest Chronic illness Updates

Fibromyalgia Stores

Click here to Visit Fibromyalgia Store

Comments